Compound information
- Natural Products
- NACP84391
- Molecular Formula
- C21H22O6
- Molecular Weight
- 370.141638424 g/mol
- Structure
-
- IUPAC Name
- 1,7-bis(4-hydroxy-3-methoxy-phenyl)hept-1-ene-3,5-dione
- InChI
- InChI=1S/C21H22O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h3,5-7,9-12,24-25H,4,8,13H2,1-2H3
- InChI Key
- MUYJSOCNDLUHPJ-UHFFFAOYSA-N
- SMILES
- O=C(C=CC1=CC=C(O)C(OC)=C1)CC(=O)CCC2=CC=C(O)C(OC)=C2
- CAS
- 76474-56-1
- SuperClass
- Phenylpropanoids and polyketides
- Class
- Diarylheptanoids
- SubClass
- Linear diarylheptanoids
- Source
- CNP0188467
Warheads
- Carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 27 | Ring Count | 2 |
Heteroatom Count | 6 | Rotatable Bond Count | 9 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 93.06 Å2 | LogP | 2.372 |
LogS | -5.606 | LogD | 2.796 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.818 | Pgp substrate | 0.003 |
HIA | 0.963 | F20 % | 0.955 |
F30 % | 0.893 | Caco-2 | -4.858 |
MDCK | -4.914 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.021 | PPB | 73.077 |
VD | 1.539 | Fu | 1.037 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.837 | CYP1A2 substrate | 0.588 |
CYP2A6 substrate | 0.434 | CYP2B6 substrate | 0.675 |
CYP2C19 inhibitor | 0.721 | CYP2C19 substrate | 0.773 |
CYP2C8 substrate | 0.807 | CYP2C9 inhibitor | 0.909 |
CYP2C9 substrate | 0.065 | CYP2D6 inhibitor | 0.297 |
CYP2D6 substrate | 0.54 | CYP2E1 substrate | 0.202 |
CYP3A4 inhibitor | 0.815 | CYP3A4 substrate | 0.073 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.987 | CL | 14.846 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.246 | Hepatotoxicity | 0.037 |
Mutagenicity | 0.007 | Rat Oral Acute Toxicity | 0.092 |
FDAMDD | 0.708 | Skin Sensitization | 0.998 |
Carcinogenicity | 0.265 | Eye Corrosion | 0.001 |
Eye Irritation | 0.698 | Respiratory Toxicity | 0.445 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.077 | IGC50 | 5.428 |
LC50FM | 5.956 | LC50DM | 4.601 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.505 | NR-AR-LBD | 0.869 |
NR-AhR | 0.573 | NR-Aromatase | 0.202 |
NR-ER | 0.832 | NR-ER-LBD | 0.64 |
NR-PPAR-gamma | 0.913 | SR-ARE | 0.479 |
SR-ATAD5 | 0.817 | SR-HSE | 0.839 |
SR-MMP | 0.771 | SR-p53 | 0.647 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.